P
PT UBC Medical Indonesia Tbk
IDX:LABS
PT UBC Medical Indonesia Tbk
IDX:LABS
Price:
146
IDR
-0.68%
Market Closed
Market Cap:
Rp576.7B
Relative Value
The Relative Value of one LABS stock under the Base Case scenario is hidden IDR. Compared to the current market price of 146 IDR, PT UBC Medical Indonesia Tbk is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LABS Relative Value
HIDDEN
Multiples Across Competitors
LABS Competitors Multiples
PT UBC Medical Indonesia Tbk Competitors
PT UBC Medical Indonesia Tbk Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| ID |
P
|
PT UBC Medical Indonesia Tbk
IDX:LABS
|
576.7B IDR | 3.3 | 62 | 37.1 | 37.1 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
115.3B USD | 0.3 | 28.6 | 20.1 | 22.6 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
68.5B USD | 0.2 | 42.2 | 14.8 | 18.7 | |
| US |
|
Cencora Inc
NYSE:COR
|
70B USD | 0.2 | 43.1 | 15.1 | 19.1 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
51.9B USD | 0.2 | 31.1 | 15 | 19.5 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
34.8B AUD | 5.8 | 65.8 | 49.6 | 49.6 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.3B USD | 0.7 | 23.7 | 11.3 | 15.8 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.8B CNY | 0.2 | 11.3 | 15.2 | 15.2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.8B CNY | 1.5 | 17.3 | 13.3 | 13.3 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
66.1B HKD | 0.1 | 8.6 | 1.6 | 2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
